Minoryx’s clinical candidate leriglitazone shows clinical benefit in a proof of concept Phase 2 study in Friedreich´s ataxia

Post by: Geert in Minoryx Press Release
Minoryx’s clinical candidate leriglitazone shows…
read more
18 Dec 2020
0

Minoryx’s preclinical data for leriglitazone in Friedreich’s Ataxia published in Neurobiology of Disease Journal

Post by: Geert in Minoryx Press Release
Minoryx’s preclinical data for leriglitazone…
read more
16 Nov 2020
0

European Investment Bank provides Minoryx with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseases

Post by: Geert in Minoryx Press Release
European Investment Bank provides Minoryx…
read more
02 Nov 2020
0

Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau

Post by: Geert in Minoryx Press Release
Minoryx Therapeutics and Sperogenix Therapeutics…
read more
23 Sep 2020
0

Minoryx Therapeutics in the news

Post by: Geert in Minoryx News article
Minoryx Therapeutics in the news
read more
18 Feb 2020
0

Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD

Post by: Geert in Minoryx Press Release
Minoryx Therapeutics receives US FDA…
read more
09 Jan 2020
0

Minoryx Therapeutics receives Orphan Drug Designation from the European Commission for leriglitazone in the treatment of Friedreich’s Ataxia

Post by: Geert in Minoryx Press Release
Minoryx Therapeutics receives Orphan Drug…
read more
13 Nov 2019
0

Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia

Post by: Geert in Minoryx Press Release
Minoryx Therapeutics receives FDA Orphan…
read more
17 Oct 2019
0

Minoryx: Un axe Espagne-Belgique pour sauter la barrière

Post by: Geert in Minoryx News article
Minoryx News Article: Un axe…
read more
09 Oct 2019
0

Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich’s Ataxia

Post by: Geert in Minoryx Press Release
Minoryx Therapeutics completes enrollment in…
read more
08 Oct 2019
0